Clinical Research Directory
Browse clinical research sites, groups, and studies.
Russian Extreme Hypertriglyceridemia Registry
Sponsor: Russian Cardiology Research and Production Center
Summary
The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.
Official title: Russian Extreme Hypertriglyceridemia Registry (REGGI)
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-11-20
Completion Date
2045-12
Last Updated
2026-04-02
Healthy Volunteers
No
Conditions
Locations (6)
Astrakhan State Medical University
Astrakhan, Russia
Chelyabinsk State Medical Academy
Chelyabinsk, Russia
Kaluga City Clinical Hospital No. 5
Kaluga, Russia
State Medical University
Kazan', Russia
National Medical Research Center of Cardiology Named after Academician E.I. Chazov
Moscow, Russia
Research Centre for Medical Genetics
Moscow, Russia